Cell 82 , 14771491 (2022)
Most of the effort has been so far devoted to the identification of medications capable to revert the worst and life-threatening complications of COVID-19, namely cytokine storm and hypercoagulation (Kowalewski et al., 2020
Nevertheless, GLP-1 therapies should not be prescribed solely for pain management without clear metabolic indications
The year 2024 alone accounted for $30 billion in alliances and acquisitions, reflecting investors growing confidence in the markets long-term potential
However, despite GLP-1 agonists higher efficacy, the higher cost makes them not cost-effective [61] in some analyses when compared to older, less expensive alternatives
*This Product is Hygroscopic (Absorbs moisture) therefore storage conditions may affect capsule quality